 |
ICON Group International, Inc. (an IG Ltd Company)
|
Industry Reports ICON Group International, Inc. (an IG Ltd Company) |
|
| Title | Pages | Price | Order/View |
|---|---|---|---|
The 2010-2015 World Outlook for Hepatitis C Virus (HCV) Therapeutics | 197 | $795 |  |
The 2010-2015 World Outlook for Multiple Myeloma Therapeutics | 196 | $795 | |
The 2010-2015 World Outlook for Prostate Cancer Therapeutics | 198 | $795 | |
The 2010-2015 World Outlook for Therapeutic Apheresis Products | 195 | $795 | |
The 2010-2015 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products | 215 | $795 | |
The 2009-2014 World Outlook for Osteoporosis Therapeutics | 196 | $795 | |
The 2009-2014 World Outlook for Therapeutic Vaccines | 195 | $795 | |
The 2009-2014 World Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics | 201 | $795 | |
The 2009-2014 World Outlook for Artificial Mixtures of Two or More Medicinal or Botanical Substances for Therapeutic or Prophylactic Uses Sold in Bulk | 201 | $795 | |
The 2009-2014 World Outlook for Diagnostic, Therapeutic, and Patient Monitoring Equipment and Other Electromedical Equipment Excluding Ionizing Radiation Equipment | 199 | $795 | |
The 2009-2014 World Outlook for Manufacturing Irradiation Apparatus and Tubes for Medical Diagnostic, Medical Therapeutic, Industrial, and Research and Scientific Evaluation Applications | 204 | $795 | |
The 2009-2014 World Outlook for Nutritional Supplements Excluding Therapeutic Dietary Foods and Infant Formulas | 199 | $795 | |
| Title | Pages | Price | Order/View |
|---|---|---|---|
The 2009-2014 Outlook for Osteoporosis Therapeutics in Africa | 56 | $325 | |
The 2009-2014 Outlook for Osteoporosis Therapeutics in Asia | 38 | $325 | |
The 2009-2014 Outlook for Osteoporosis Therapeutics in Europe | 54 | $325 | |
The 2009-2014 Outlook for Osteoporosis Therapeutics in Oceana | 34 | $325 | |
The 2009-2014 Outlook for Osteoporosis Therapeutics in The Americas & the Caribbean | 54 | $325 | |
The 2009-2014 Outlook for Osteoporosis Therapeutics in The Middle East | 36 | $325 | |
The 2009-2014 Outlook for Therapeutic Vaccines in Africa | 56 | $325 | |
The 2009-2014 Outlook for Therapeutic Vaccines in Asia & the Middle East | 56 | $325 | |
The 2009-2014 Outlook for Therapeutic Vaccines in Europe | 54 | $325 | |
The 2009-2014 Outlook for Therapeutic Vaccines in Latin America | 35 | $325 | |
The 2009-2014 Outlook for Therapeutic Vaccines in North America & the Caribbean | 37 | $325 | |
The 2009-2014 Outlook for Therapeutic Vaccines in Oceana | 34 | $325 | |
The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in Oceana | 34 | $325 | |
The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in The Americas & the Caribbean | 54 | $325 | |
The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in The Middle East | 36 | $325 | |
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Oceana | 34 | $325 | |
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in The Americas & the Caribbean | 54 | $325 | |
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in The Middle East | 36 | $325 | |
The 2010-2015 Outlook for Prostate Cancer Therapeutics in Latin America | 35 | $325 | |
The 2010-2015 Outlook for Prostate Cancer Therapeutics in North America & the Caribbean | 37 | $325 | |
The 2010-2015 Outlook for Prostate Cancer Therapeutics in Oceana | 34 | $325 | |
The 2010-2015 Outlook for Prostate Cancer Therapeutics in The Middle East | 36 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in Latin America | 35 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in North America & the Caribbean | 37 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in Oceana | 34 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in The Americas & the Caribbean | 54 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in The Middle East | 36 | $325 | |
The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Latin America | 37 | $325 | |
The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean | 38 | $325 | |
The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Oceana | 35 | $325 | |
The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in Africa | 56 | $325 | |
The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in Asia | 38 | $325 | |
The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in Europe | 55 | $325 | |
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Africa | 56 | $325 | |
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Asia | 38 | $325 | |
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Europe | 54 | $325 | |
The 2010-2015 Outlook for Prostate Cancer Therapeutics in Africa | 56 | $325 | |
The 2010-2015 Outlook for Prostate Cancer Therapeutics in Asia | 38 | $325 | |
The 2010-2015 Outlook for Prostate Cancer Therapeutics in Europe | 54 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in Africa | 58 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in Africa, Europe & the Middle East | 112 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in Asia | 38 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in Asia & Oceana | 56 | $325 | |
The 2010-2015 Outlook for Therapeutic Apheresis Products in Europe | 54 | $325 | |
The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Africa & the Middle East | 84 | $325 | |
The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Asia | 40 | $325 | |
The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Europe | 57 | $325 | |
| Country | Title | Pages | Price | Order/View |
|---|---|---|---|---|
| China | The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China | 141 | $495 | |
| India | The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in India | 319 | $495 | |
| USA | The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States | 731 | $495 | |
| China | The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Greater China | 141 | $495 | |
| India | The 2010-2015 Outlook for Multiple Myeloma Therapeutics in India | 319 | $495 | |
| USA | The 2010-2015 Outlook for Multiple Myeloma Therapeutics in the United States | 731 | $495 | |
| China | The 2010-2015 Outlook for Prostate Cancer Therapeutics in Greater China | 141 | $495 | |
| India | The 2010-2015 Outlook for Prostate Cancer Therapeutics in India | 319 | $495 | |
| USA | The 2010-2015 Outlook for Prostate Cancer Therapeutics in the United States | 731 | $495 | |
| China | The 2010-2015 Outlook for Therapeutic Apheresis Products in Greater China | 141 | $495 | |
| India | The 2010-2015 Outlook for Therapeutic Apheresis Products in India | 235 | $495 | |
| USA | The 2010-2015 Outlook for Therapeutic Apheresis Products in the United States | 565 | $495 | |
| China | The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China | 143 | $495 | |
| India | The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India | 330 | $495 | |
| USA | The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States | 746 | $495 | |
| Japan | The 2010-2015 Outlook for Hepatitis C Virus (HCV) Therapeutics in Japan | 141 | $495 | |
| Japan | The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Japan | 141 | $495 | |
| Japan | The 2010-2015 Outlook for Prostate Cancer Therapeutics in Japan | 141 | $495 | |
| Japan | The 2010-2015 Outlook for Therapeutic Apheresis Products in Japan | 141 | $495 | |
| Japan | The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Japan | 170 | $495 | |
| India | The 2009-2014 Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics in India | 336 | $495 | |
| India | The 2009-2014 Outlook for Diagnostic, Therapeutic, and Patient Monitoring Equipment and Other Electromedical Equipment Excluding Ionizing Radiation Equipment in India | 336 | $495 | |
| India | The 2009-2014 Outlook for Nutritional Supplements Excluding Therapeutic Dietary Foods and Infant Formulas in India | 333 | $495 | |
| Japan | The 2009-2014 Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics in Japan | 170 | $495 | |
| Japan | The 2009-2014 Outlook for Diagnostic, Therapeutic, and Patient Monitoring Equipment and Other Electromedical Equipment Excluding Ionizing Radiation Equipment in Japan | 170 | $495 | |
| Japan | The 2009-2014 Outlook for Nutritional Supplements Excluding Therapeutic Dietary Foods and Infant Formulas in Japan | 170 | $495 | |
| USA | The 2009-2014 Outlook for Diagnostic, Therapeutic, and Patient Monitoring Equipment and Other Electromedical Equipment Excluding Ionizing Radiation Equipment in the United States | 751 | $495 | |
| USA | The 2009-2014 Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics in the United States | 750 | $495 | |
| USA | The 2009-2014 Outlook for Nutritional Supplements Excluding Therapeutic Dietary Foods and Infant Formulas in the United States | 749 | $495 | |
| China | The 2009-2014 Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics in Greater China | 144 | $495 | |
| China | The 2009-2014 Outlook for Diagnostic, Therapeutic, and Patient Monitoring Equipment and Other Electromedical Equipment Excluding Ionizing Radiation Equipment in Greater China | 144 | $495 | |
| China | The 2009-2014 Outlook for Nutritional Supplements Excluding Therapeutic Dietary Foods and Infant Formulas in Greater China | 144 | $495 | |
| China | The 2009-2014 Outlook for Osteoporosis Therapeutics in Greater China | 141 | $495 | |
| India | The 2009-2014 Outlook for Osteoporosis Therapeutics in India | 319 | $495 | |
| Japan | The 2009-2014 Outlook for Osteoporosis Therapeutics in Japan | 141 | $495 | |
| USA | The 2009-2014 Outlook for Osteoporosis Therapeutics in the United States | 731 | $495 | |
| China | The 2009-2014 Outlook for Therapeutic Vaccines in Greater China | 141 | $495 | |
| India | The 2009-2014 Outlook for Therapeutic Vaccines in India | 318 | $495 | |
| Japan | The 2009-2014 Outlook for Therapeutic Vaccines in Japan | 141 | $495 | |
| USA | The 2009-2014 Outlook for Therapeutic Vaccines in the United States | 731 | $495 | |
| Title | Pages | Price | Order/View |
|---|---|---|---|
The 2010 Report on Hepatitis C Virus (HCV) Therapeutics: World Market Segmentation by City | 329 | $795 | |
The 2010 Report on Multiple Myeloma Therapeutics: World Market Segmentation by City | 329 | $795 | |
The 2010 Report on Prostate Cancer Therapeutics: World Market Segmentation by City | 329 | $795 | |
The 2010 Report on Therapeutic Apheresis Products: World Market Segmentation by City | 329 | $795 | |
The 2010 Report on Therapeutic Monoclonal Antibody (Mab)-Based Products: World Market Segmentation by City | 329 | $795 | |
The 2009 Report on Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics: World Market Segmentation by City | 347 | $795 | |
The 2009 Report on Artificial Mixtures of Two or More Medicinal or Botanical Substances for Therapeutic or Prophylactic Uses Sold in Bulk: World Market Segmentation by City | 342 | $795 | |
The 2009 Report on Diagnostic, Therapeutic, and Patient Monitoring Equipment and Other Electromedical Equipment Excluding Ionizing Radiation Equipment: World Market Segmentation by City | 343 | $795 | |
The 2009 Report on Manufacturing Irradiation Apparatus and Tubes for Medical Diagnostic, Medical Therapeutic, Industrial, and Research and Scientific Evaluation Applications: World Market Segmentation by City | 355 | $795 | |
The 2009 Report on Nutritional Supplements Excluding Therapeutic Dietary Foods and Infant Formulas: World Market Segmentation by City | 341 | $795 | |
The 2009 Report on Osteoporosis Therapeutics: World Market Segmentation by City | 329 | $795 | |
The 2009 Report on Therapeutic Vaccines: World Market Segmentation by City | 329 | $795 | |
Global Trade Perspective Reports:
| Title | Pages | Price | Order/View |
|---|---|---|---|
The World Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus: A 2009 Global Trade Perspective | 196 | $595 | |
| Type | Title | Pages | Price | Order/View |
|---|---|---|---|---|
| Imports | The 2009 World Market Forecasts for Imported Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus | 126 | $325 | |
| Exports | The 2009 World Forecasts of Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus Export Supplies | 91 | $325 | |
| Title | Pages | Price | Order/View |
|---|---|---|---|
The 2009 Import and Export Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus in Africa | 34 | $325 | |
The 2009 Import and Export Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus in Asia | 49 | $325 | |
The 2009 Import and Export Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus in Europe | 82 | $325 | |
The 2009 Import and Export Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus in Latin America | 44 | $325 | |
The 2009 Import and Export Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus in North America & the Caribbean | 31 | $325 | |
The 2009 Import and Export Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus in Oceana | 28 | $325 | |
The 2009 Import and Export Market for Ozone Therapy, Oxygen Therapy, Aerosol Therapy, Artificial Respiration, and Other Therapeutic Respiration Apparatus in the Middle East | 38 | $325 | |
Performance Benchmarking & Productivity Gap Analysis
| Country | Title | Last Updated | Pages | Price | Order/View |
|---|---|---|---|---|---|
| United States | AMERICAN SCIENCE AND ENGINEERING, INC.: International Competitive Benchmarks and Financial Gap Analysis (others in sector) | 1/2010 | 80 | $210 | |
| United States | AMERICAN SCIENCE AND ENGINEERING, INC.: Labor Productivity Benchmarks and International Gap Analysis (others in sector) | 1/2010 | 60 | $210 | |
| United States | HOLOGIC, INC.: International Competitive Benchmarks and Financial Gap Analysis (others in sector) | 1/2010 | 80 | $210 | |
| United States | HOLOGIC, INC.: Labor Productivity Benchmarks and International Gap Analysis (others in sector) | 1/2010 | 60 | $210 | |
| United States | PHOTOELECTRON CORPORATION: International Competitive Benchmarks and Financial Gap Analysis (others in sector) | 1/2010 | 80 | $210 | |
| United States | PHOTOELECTRON CORPORATION: Labor Productivity Benchmarks and International Gap Analysis (others in sector) | 1/2010 | 60 | $210 | |
More companies, select a country: | |||||
Benchmark and Gap Analysis Reports:
| Country | Title | Last Updated | Pages | Price | Order/View |
|---|---|---|---|---|---|
| United States | ANIKA THERAPEUTICS, INC.: International Competitive Benchmarks and Financial Gap Analysis (others in sector) | 1/2010 | 24 | $210 | |
| United States | ANIKA THERAPEUTICS, INC.: Labor Productivity Benchmarks and International Gap Analysis (others in sector) | 1/2010 | 20 | $210 | |
| C, G, I, L, M, N, U | |||||
More companies, select a country: | |||||
Health Publications:
| Disease | Title | Pages | Price | Order/View |
|---|---|---|---|---|
Artificial Insemination | Artificial Insemination - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References | 204 | $28.95 | |
For more information about ICON Group International's publications and services, please feel free to contact us:
ICON Group International, Inc.
7404 Trade St.
San Diego, CA 92121
USA
Fax: (858) 635-9414
Email: 
Back | Top | Disclaimers | ICON Home
